Interview with Wolfgang Grisold at ICNMD 2026

In a recent interview regarding the upcoming ICNMD (International Congress on Neuromuscular Diseases) 2026, Wolfgang Grisold discussed several key topics surrounding advancements in neuromuscular research and patient care. The congress, which is set to take place in 2026, aims to bring together experts in the field to share knowledge, present the latest research findings, and collaborate on improving treatments for neuromuscular disorders.

Grisold emphasized the importance of multidisciplinary approaches in neuromuscular medicine, highlighting how collaboration among neurologists, geneticists, physiotherapists, and researchers can lead to more effective treatments. He also stressed the need for ongoing education and awareness about neuromuscular diseases to ensure that healthcare professionals are equipped to provide the best care for patients.

Additionally, Grisold discussed the role of emerging technologies in diagnosing and treating neuromuscular conditions, such as advancements in imaging techniques and genetic therapies. He expressed optimism about the future of neuromuscular medicine, particularly in light of recent breakthroughs that could significantly improve quality of life for affected individuals.

The ICNMD 2026 is expected to attract researchers, clinicians, and industry leaders from around the globe and will likely feature a wide array of sessions covering the latest developments in the field. Details surrounding the event, including its location and schedule, will be made available closer to the date.